Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 9, 2013 - Issue 9
Submit an article Journal homepage
1,117
Views
31
CrossRef citations to date
0
Altmetric
Research Paper

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles

Suvi Lappalainen Vaccine Research Center; University of Tampere Medical School; Tampere, Finland
,
Kirsi Tamminen Vaccine Research Center; University of Tampere Medical School; Tampere, Finland
,
Timo Vesikari Vaccine Research Center; University of Tampere Medical School; Tampere, Finland
&
Vesna Blazevic Vaccine Research Center; University of Tampere Medical School; Tampere, FinlandCorrespondence[email protected]
Pages 1991-2001 | Received 12 Feb 2013, Accepted 01 Jun 2013, Published online: 18 Jun 2013

Citations (31)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Yuxiao Wang, Jingxin Li, Pei Liu & Fengcai Zhu. (2021) The performance of licensed rotavirus vaccines and the development of a new generation of rotavirus vaccines: a review. Human Vaccines & Immunotherapeutics 17:3, pages 880-896.
Read now
Vesna Blazevic, Maria Malm, Daisuke Arinobu, Suvi Lappalainen & Timo Vesikari. (2016) Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Human Vaccines & Immunotherapeutics 12:3, pages 740-748.
Read now
Miguel O’Ryan, Roberto Vidal, Felipe del Canto, Juan Carlos Salazar & David Montero. (2015) Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae. Human Vaccines & Immunotherapeutics 11:3, pages 584-600.
Read now
Suvi Lappalainen, Ana Ruth Pastor, Kirsi Tamminen, Vanessa López-Guerrero, Fernando Esquivel-Guadarrama, Laura A Palomares, Timo Vesikari & Vesna Blazevic. (2014) Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Human Vaccines & Immunotherapeutics 10:7, pages 2039-2047.
Read now
. (2013) Landes Highlights. Gut Microbes 4:6, pages 423-424.
Read now

Articles from other publishers (26)

Yang Li, Yaxuan Li, Weidong Liu, Baorui Wang, Ping Wang & Yanwei Qi. (2023) Th2/Th1 cytokine imbalance is associated with higher recurrent intussusception incidence in children: A 10-year retrospective study of 1657 patients. Medicine 102:13, pages e33391.
Crossref
Tatsuya Kato, Tatsuki Kakuta, Ami Yonezuka, Tomofumi Sekiguchi, Yuki Machida, Jian Xu, Tohru Suzuki & Enoch Y. Park. (2022) Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate. Molecular Biotechnology 65:3, pages 401-409.
Crossref
Zabihollah Shoja, Somayeh Jalilvand, Tayebeh Latifi & Farzin Roohvand. (2022) Rotavirus VP6: involvement in immunogenicity, adjuvant activity, and use as a vector for heterologous peptides, drug delivery, and production of nano-biomaterials. Archives of Virology 167:4, pages 1013-1023.
Crossref
Cao Li, Guoxing Luo, Yuanjun Zeng, Feibo Song, Han Yang, Shiyin Zhang, Yingbin Wang, Tingdong Li, Shengxiang Ge & Ningshao Xia. (2022) Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production. Vaccines 10:2, pages 243.
Crossref
Atefeh Afchangi, Somayeh Jalilvand, Arash Arashkia, Tayebeh Latifi, Mohammad Farahmand, Maryam Mashhadi Abolghasem Shirazi, Seyed Dawood Mousavi Nasab, Sayed Mahdi Marashi, Farzin Roohvand & Zabihollah Shoja. (2022) Co-administration of rotavirus nanospheres VP6 and NSP4 proteins enhanced the anti-NSP4 humoral responses in immunized mice. Microbial Pathogenesis 163, pages 105405.
Crossref
Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn & Vesna Blazevic. (2021) Fusion Protein of Rotavirus VP6 and SARS-CoV-2 Receptor Binding Domain Induces T Cell Responses. Vaccines 9:7, pages 733.
Crossref
Kirsi Tamminen, Suvi Heinimäki, Stina Gröhn & Vesna Blazevic. (2020) Internalization and antigen presentation by mouse dendritic cells of rotavirus VP6 preparations differing in nanostructure. Molecular Immunology 123, pages 26-31.
Crossref
Suvi Heinimäki, Minna M. Hankaniemi, Amir-Babak Sioofy-Khojine, Olli H. Laitinen, Heikki Hyöty, Vesa P. Hytönen, Timo Vesikari & Vesna Blazevic. (2019) Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus. Vaccine 37:51, pages 7509-7518.
Crossref
Zhipeng Li, Kuiqing Cui, Kongwei Huang, Fuhang Liu, Deshun Shi & Qingyou Liu. (2019) Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice. Protein & Peptide Letters 26:12, pages 904-909.
Crossref
Maria Malm, Heikki Hyöty, Mikael Knip, Timo Vesikari & Vesna Blazevic. (2019) Development of T cell immunity to norovirus and rotavirus in children under five years of age. Scientific Reports 9:1.
Crossref
Atefeh Afchangi, Somayeh Jalilvand, Nasir Mohajel, Sayed Mahdi Marashi & Zabihollah Shoja. (2019) Rotavirus VP6 as a potential vaccine candidate. Reviews in Medical Virology 29:2, pages e2027.
Crossref
Suvi Heinimäki, Maria Malm, Timo Vesikari & Vesna Blazevic. (2018) Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4 + T lymphocytes with cytotoxic potential. Antiviral Research 157, pages 1-8.
Crossref
Atefeh AfchangiArash ArashkiaZahra ShahosseiniSomayeh JalilvandSayed Mahdi MarashiFarzin RoohvandNasir MohajelZabihollah Shoja. (2018) Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone. Viral Immunology 31:3, pages 233-241.
Crossref
O. A. Kondakova, N. A. Nikitin, E. A. Trifonova, J. G. Atabekov & O. V. Karpova. (2018) Rotavirus Vaccines: New Strategies and Approaches. Moscow University Biological Sciences Bulletin 72:4, pages 169-178.
Crossref
M Malm, S Heinimäki, T Vesikari & V Blazevic. (2017) Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs. Clinical and Experimental Immunology 189:3, pages 331-341.
Crossref
Suvi Lappalainen, Vesna Blazevic, Maria Malm & Timo Vesikari. (2017) Rotavirus vaccination and infection induce VP6-specific IgA responses. Journal of Medical Virology 89:2, pages 239-245.
Crossref
Albertina Cárdenas-VargasDarwin Elizondo-QuirogaAbel Gutierrez-OrtegaClaudia Charles-NiñoCésar Pedroza-Roldán. (2016) Evaluation of the Immunogenicity of a Potyvirus-Like Particle as an Adjuvant of a Synthetic Peptide. Viral Immunology 29:10, pages 557-564.
Crossref
Suvi Lappalainen, Timo Vesikari & Vesna Blazevic. (2016) Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins. Archives of Virology 161:11, pages 3219-3223.
Crossref
Maria Malm, Kirsi Tamminen, Timo Vesikari & Vesna Blazevic. (2016) Type-specific and cross-reactive antibodies and T cell responses in norovirus VLP immunized mice are targeted both to conserved and variable domains of capsid VP1 protein. Molecular Immunology 78, pages 27-37.
Crossref
X.-X. Pan, B.-X. Zhao, Y.-M. Teng, W.-Y. Xia, J. Wang, X.-F. Li, G.-Y. Liao, C. Yang & Y.-D. Chen. (2016) Immunoreactivity of chimeric proteins carrying poliovirus epitopes on the VP6 of rotavirus as a vector. Molecular Biology 50:5, pages 731-739.
Crossref
Maria Malm, Kirsi Tamminen, Suvi Lappalainen, Timo Vesikari & Vesna Blazevic. (2016) Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles. Journal of Immunology Research 2016, pages 1-13.
Crossref
Lo?c Etienne, Emmanuelle Blanchard, Audrey Boyer, Virginie Desvignes, Julien Gaillard, Jean-Christophe Meunier, Philippe Roingeard & Christophe Hourioux. (2015) The Replacement of 10 Non-Conserved Residues in the Core Protein of JFH-1 Hepatitis C Virus Improves Its Assembly and Secretion. PLOS ONE 10:9, pages e0137182.
Crossref
Suvi Lappalainen, Ana Ruth Pastor, Maria Malm, Vanessa López-Guerrero, Fernando Esquivel-Guadarrama, Laura A. Palomares, Timo Vesikari & Vesna Blazevic. (2015) Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine. Archives of Virology 160:8, pages 2075-2078.
Crossref
Somayeh Jalilvand, Sayed Mahdi Marashi & Zabihollah Shoja. (2015) Rotavirus VP6 preparations as a non-replicating vaccine candidates. Vaccine 33:29, pages 3281-3287.
Crossref
Ulrich Desselberger. (2014) Rotaviruses. Virus Research 190, pages 75-96.
Crossref
Yumei TengBingxin ZhaoXiaoxia PanYuling WenYuanding Chen. (2014) A New Rotavirus VP6-Based Foreign Epitope Presenting Vector and Immunoreactivity of VP4 Epitope Chimeric Proteins. Viral Immunology 27:3, pages 96-104.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.